Peripheral vessel wall changes in hypertensive patients with gout

Shelest B.A.

doi:https://doi.org/10.17116/terarkh201688543-46

Shelest B.A.

Kharkov National Medical University, Kharkov, Ukraine

Peripheral vessel wall changes in hypertensive patients with gout

Authors:

Shelest B.A.

More about the authors

Journal: Therapeutic Archive. 2016;88(5): 43‑46

DOI: 10.17116/terarkh201688543-46

Read: 2732 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Shelest BA. Peripheral vessel wall changes in hypertensive patients with gout. Therapeutic Archive. 2016;88(5):43‑46. (In Russ.)
https://doi.org/10.17116/terarkh201688543-46

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

The significance of exogenous nitrate and nitrite of plant origin for vascular health. Russian Journal of Preventive Medicine. 2024;(11):141-146

The improvement of the specialized medical care for patients with peripheral arterial atherosclerosis in the Yaroslavl region. Russian Journal of Preventive Medicine. 2024;(12):16-23

Predictors of Engagement and Active participation of Patients with Uncontrolled Hypertension in the Telehealth Surveillance Program. Russian Journal of Preventive Medicine. 2024;(12):37-43

Efficacy and tolerability of azilsartan combined with amlodipine and amlodipine monotherapy and combinations of amlodipine with other angiotensin II receptor blockers. Russian Cardiology Bulletin. 2024;(4-2):161-171

Risk factors and adverse outcomes of cardiovascular diseases in people with high normal blood pressure of the Ryazan region. (5-year prospective follow-up). Russian Journal of Preventive Medicine. 2025;(2):31-37

Diagnostics of hypertensive disorders in cardio-obstetrics: current state-of-affairs. Russian Journal of Human Reproduction. 2025;(1):63-77

Study of the levocarnitine efficacy for the treatment of moderate cognitive impairment in patients with hypertension. Russian Journal of Preventive Medicine. 2025;(4):45-50

Visceral obesity is a reversible factor in pathogenesis of major cardiovascular diseases. Russian Cardiology Bulletin. 2025;(3):11-16

Tibial autovenous bypass with single-segment and spliced vein. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(5):534-538

Features of the interpretation of bodily sensations by patients with arterial hypertension. Russian Journal of Preventive Medicine. 2025;(10):82-87

Abstract:

Aim. To investigate the specific features of arterial wall endothelial dysfunction and stiffness in patients with hypertension concurrent with gout. Subjects and methods. A total of 54 patients were examined and divided into 2 groups. A study group consisted of 33 hypertensive patients with gout and a comparison group included 21 hypertensive patients without hyperuricemia. The patients did not differ in blood pressure (BP) readings. Uric acid was determined by the reaction with tungstophosphoric solution AT (Reagent, Dnepropetrovsk, Ukraine). The validity of results was checked using the control sera (Biocont C, Russia). Enzyme immunoassays and Doppler studies were used to investigate peripheral vasoregulation. Body mass index, intima-media thickness (IMT), pulse wave velocity (PWV), cardio-ankle vascular index (CAVI), endothelin-1 (ET-1), and endothelium-dependent vasodilation (EDVD) were determined. Results. All the studied indicators have directly or indirectly a negative impact, by deteriorating the function of the vessel wall. The found arterial structural changes suggest that there is an early atheromatous process in the arterial wall of hypertensive patients with gout. Addition of gout promotes endothelial dysfunction and worsens the course of hypertension. An elevation of indicators, such as PWV, CAVI, and ET-1 levels, has the poorest prognosis for the course of hypertension. Conclusion. The determination of CAVI, PWV, ET-1 levels, arterial stiffness index along with additional criteria, such as EDVD and IMT, may be used as criteria for a cardiovascular risk in hypertensive patients.

Keywords:

hypertension

gout

endothelin

peripheral arteries

Doppler study

Authors:

Shelest B.A.

Kharkov National Medical University, Kharkov, Ukraine

Close metadata

References:

Iljina A, Barskova V, Nasonov E. Gout, hyperuricemia and cardiovascular risk. Nauchno-prakticheskaya revmatologiya. 2009;10(1):56-53. (In Russ.) doi:10.14412/1995-4484-2009-143.
Primatesta P, Plana E, Rothenbacher D. Gout treatment and comorbidities: a retrospective cohort study in a large US man-aged care population. BMC Musculoskelet Disord. 2011;12:103. doi:10.1186/1471-2474-12-103.
Uday M Khosla, Sergey Zharikov, Jennifer L Finch, Takahiko Nakagawa, Carlos Roncal, Wei Mu, Karina Krotova, Edward R Block, Sharma Prabhakar, Richard J Johnson. Hyperuricemia induces endothelial dysfunction. Kidney Int. 2005;67:1739-1742. doi:10.1111/j.1523-1755.2005.00273.x.
Kovalenko V, Nesukaj O, Jakovenko G. Ultrasound examination of the brachiocephalic vessels in patients with metabolic syndrome and hyperuricemia. Ukrai'ns'kyj medychnyj al'manah. 2008;11(4):71-73. (In Ukr.)
Shirai K, Hiruta N, Song M, Kurosu T, Suzuki J, Tomaru T, Miyashita Y, Saiki A, Takahashi M, Suzuki K, Takata M. Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J Atheroscler Thromb. 2011;18(11):924-938. doi:10.5551/jat.7716.
Okura T, Watanabe S, Kurata M, Manabe S, Koresawa M, Irita J, Enomoto D, Miyoshi K, Fukuoka T, Higaki J. Relationship between Cardio-Ankle Vascular Index (CAVI) and carotid aterosclerosis in patients with essential hypertension. Hypertens Res. 2007;30(4):335-340. doi:10.1291/hypres.30.335.
Sirenko Ju, Radchenko G, Kushnir S. Pulse pressure and aortic stiffness index: the impact on the prognosis of patients with hypertension treated in a specialized department. Arterial'na gipertenzija. 2009;2(4):25-58. (In Ukr.)
Celermajer DS, Sorensen KE, Gooh VM. Noninvasive detection of endothelial dysfunction in children and adults at risk atherosclerosis. Lancet. 1999;340:1111-1115. doi:10.1016/0140-6736(92)93147-F.
Carmelinda Ruggiero, Antonio Cherubini, Alessandro Ble, Angelo JG Bos, Marcello Maggio, Vishwa D Dixit, Fulvio Lauretani, Stefania Bandinelli, Umberto Senin, Luigi Ferrucci Uric acid and inflammatory markers. Eur Heart J. 2005;27(10):1174-1181. doi:10.1093/eurheartj/ehi879.
Lottmann K, Chen X, Schedlich P.K. Association between gout and all-cause as well as cardiovascular mortality: a systematic review. Curr Rheumatol Rep. 2012;14(2):195-203. doi:10.1007/s11926-011-0234-2.